Publications by authors named "Anastasia Raptis"
Aliment Pharmacol Ther
May 2024
Article Synopsis
- A study assessed the prevalence of at-risk metabolic dysfunction-associated steatohepatitis (at-risk MASH) using liver MRI data from 40,189 UK Biobank participants.
- Among those, 27% showed signs of steatotic liver disease (SLD), with 89% classified as metabolic dysfunction-associated steatotic liver disease (MASLD) and only 2.2% identified as at-risk MASH, which is 0.6% of the general population.
- The at-risk MASH group had the highest liver fat and BMI, indicating severe metabolic and inflammatory issues, with notable differences in prevalence based on sex and BMI that highlight the need for targeted treatment strategies.
